NF-κB in Cellular Senescence and Cancer Treatment

被引:98
作者
Jing, Hua [1 ,2 ]
Lee, Soyoung [1 ,2 ]
机构
[1] Charite, MKFZ, D-13353 Berlin, Germany
[2] Max Delbruck Ctr Mol Med, Berlin, Germany
关键词
cancer; chemotherapy; NF-kappa B; senescence; ONCOGENE-INDUCED SENESCENCE; TRANSCRIPTIONAL REGULATION; ENDOTHELIAL-CELLS; MULTIPLE-MYELOMA; UBIQUITIN LIGASE; T-LYMPHOCYTES; TUMOR-CELLS; DNA-DAMAGE; LYMPHOMA; ACTIVATION;
D O I
10.14348/molcells.2014.2353
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The NF-kappa B pathway transcriptionally controls a large set of target genes that play important roles in cell survival, inflammation, and immune responses. While many studies showed anti-tumorigenic and pro-survival role of NF-kappa B in cancer cells, recent findings postulate that NF-kappa B participates in a senescence-associated cytokine response, thereby suggesting a tumor restraining role of NF-kappa B. In this review, we discuss implications of the NF-kappa B signaling pathway in cancer. Particularly, we emphasize the connection of NF-kappa B with cellular senescence as a response to chemotherapy, and furthermore, present examples how distinct oncogenic network contexts surrounding NF-kappa B produce fundamentally different treatment outcomes in aggressive B-cell lymphomas as an example.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 70 条
  • [1] Chemokine signaling via the CXCR2 receptor reinforces senescence
    Acosta, Juan C.
    O'Loghlen, Ana
    Banito, Ana
    Guijarro, Maria V.
    Augert, Arnaud
    Raguz, Selina
    Fumagalli, Marzia
    Da Costa, Marco
    Brown, Celia
    Popov, Nikolay
    Takatsu, Yoshihiro
    Melamed, Jonathan
    di Fagagna, Fabrizio d'Adda
    Bernard, David
    Hernando, Eva
    Gil, Jesus
    [J]. CELL, 2008, 133 (06) : 1006 - 1018
  • [2] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
    Alizadeh, AA
    Eisen, MB
    Davis, RE
    Ma, C
    Lossos, IS
    Rosenwald, A
    Boldrick, JG
    Sabet, H
    Tran, T
    Yu, X
    Powell, JI
    Yang, LM
    Marti, GE
    Moore, T
    Hudson, J
    Lu, LS
    Lewis, DB
    Tibshirani, R
    Sherlock, G
    Chan, WC
    Greiner, TC
    Weisenburger, DD
    Armitage, JO
    Warnke, R
    Levy, R
    Wilson, W
    Grever, MR
    Byrd, JC
    Botstein, D
    Brown, PO
    Staudt, LM
    [J]. NATURE, 2000, 403 (6769) : 503 - 511
  • [3] Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
    Annunziata, Christina M.
    Davis, R. Eric
    Demchenko, Yulia
    Bellamy, William
    Gabrea, Ana
    Zhan, Fenghuang
    Lenz, Georg
    Hanamura, Ichiro
    Wright, George
    Xiao, Wenming
    Dave, Sandeep
    Hurt, Elaine M.
    Tan, Bruce
    Zhao, Hong
    Stephens, Owen
    Santra, Madhumita
    Williams, David R.
    Dang, Lenny
    Barlogie, Bart
    Shaughnessy, John D., Jr.
    Kuehl, W. Michael
    Staudt, Louis M.
    [J]. CANCER CELL, 2007, 12 (02) : 115 - 130
  • [4] IKK- and NF-κB-Mediated Functions in Carcinogenesis
    Arkan, Melek C.
    Greten, Florian R.
    [J]. NF-KB IN HEALTH AND DISEASE, 2011, 349 : 159 - 169
  • [5] Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
    Baldwin, AS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) : 241 - 246
  • [6] Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
    Basseres, D. S.
    Baldwin, A. S.
    [J]. ONCOGENE, 2006, 25 (51) : 6817 - 6830
  • [7] Requirement of the NF-κB Subunit p65/RelA for K-Ras-Induced Lung Tumorigenesis
    Basseres, Daniela S.
    Ebbs, Aaron
    Levantini, Elena
    Baldwin, Albert S.
    [J]. CANCER RESEARCH, 2010, 70 (09) : 3537 - 3546
  • [8] Inflammation meets cancer, with NF-κB as the matchmaker
    Ben-Neriah, Yinon
    Karin, Michael
    [J]. NATURE IMMUNOLOGY, 2011, 12 (08) : 715 - 723
  • [9] The two NF-κB activation pathways and their role in innate and adaptive immunity
    Bonizzi, G
    Karin, M
    [J]. TRENDS IN IMMUNOLOGY, 2004, 25 (06) : 280 - 288
  • [10] Oncogene-induced senescence as an initial barrier in lymphoma development
    Braig, M
    Lee, S
    Loddenkemper, C
    Rudolph, C
    Peters, AHFM
    Schlegelberger, B
    Stein, H
    Dörken, B
    Jenuwein, T
    Schmitt, CA
    [J]. NATURE, 2005, 436 (7051) : 660 - 665